Limited liver surgery for bile duct cancer
Part of Cancer clinical trials.
This trial tests a surgery that removes only a small part of the liver to treat bile duct cancer where the bile ducts exit the liver. It may help people whose cancer has not spread beyond the bile duct area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with bile duct cancer at the liver hilum (where the bile ducts leave the liver), or doctors strongly suspect it based on tests.
- You are able to understand and follow the study procedures.
- You are willing and able to sign a consent form before any study-related tests or procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether removing a piece of a blood vessel along with the tumor during surgery helps people with hilar cholangiocarcinoma live longer and have fewer complications. It reviews past patient records to compare outcomes.
This trial tests whether combining proton beam therapy (a precise type of radiation) with a liver transplant can help people with a certain bile duct cancer (hilar cholangiocarcinoma). It may be a new option for those who cannot have surgery to remove the cancer.
This trial tests whether a liver transplant can help people with a specific type of bile duct cancer (perihilar) that cannot be removed with surgery. It aims to offer a potential cure for those whose tumor is small and hasn't spread.
This trial tests if a liver transplant can help people with a certain type of bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. Before the transplant, you would receive radiation therapy (SIRT) and chemotherapy to shrink the tumor.
This study tests whether robot-assisted surgery is safe and effective for people with perihilar cholangiocarcinoma (a type of bile duct cancer). It may be a good fit for patients whose cancer has not spread and who are healthy enough for major surgery.
This trial tests whether a liver transplant from a living donor can help people with a certain bile duct cancer that hasn't spread. It is for patients whose cancer is stable or smaller after chemotherapy.
Hear when a new Cholangiocarcinoma, Hilar trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.